Desmosomes are prominent cell-cell adhesive junctions found in a variety of epithelial tissues, including the oral epithelium. The transmembrane core of the desmosome is composed of the desmosomal cadherins that interact extracellularly to mediate cell-cell adhesion. The cytoplasmic domain of desmosomal cadherins interact with plaque proteins that in turn interact with the keratin intermediate filament cytoskeleton. Plakophilin 1 is a major desmosomal plaque component that functions to recruit intermediate filaments to sites of cell-cell contact via interactions with desmoplakin. Decreased assembly of desmosomes has been reported in several epithelial cancers. We examined plakophilin-1 expression in an esophageal squamous cell carcinoma tissue microarray and found that plakophilin-1 expression inversely correlates with tumor grade. In addition, we sought to investigate the effect of plakophilin-1 expression on desmosome assembly and cell motility in oral squamous cell carcinoma cell lines. Cell lines expressing altered levels of plakophilin-1 were generated and the ability of these cells to recruit desmoplakin to sites of cell-cell contact was examined. Our results show that decreased expression of plakophilin-1 results in decreased desmosome assembly and increased cell motility and invasion. These data lead us to propose that loss of plakophilin-1 expression during head and neck squamous cell carcinoma (HNSCC) progression may contribute to an invasive phenotype.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15419060701463082 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of Biomarkers of Arrhythmogenic Cardiomyopathy (ACM) by Plasma Proteomics.
Medicina (Kaunas)
January 2025
Service de Cardiologie Pédiatrique, Hôpital la Rabta Tunis, Tunis 1007, Tunisia.
The pathophysiology of arrhythmogenic cardiomyopathy (ACM), previously known as arrhythmogenic right ventricular cardiomyopathy (ARVC), and its specific biological features remain poorly understood. High-throughput plasma proteomic profiling, a powerful tool for gaining insights into disease pathophysiology at the systems biology level, has not been used to study ACM. This study aimed at characterizing plasmatic protein changes in patients with ACM, which were compared with those of healthy controls, and at exploring the potential role of the identified proteins as biomarkers for diagnosis and monitoring.
View Article and Find Full Text PDFRobotic manipulation of cardiomyocytes to identify gap junction modifiers for arrhythmogenic cardiomyopathy.
Sci Robot
October 2024
Program in Molecular Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Arrhythmogenic cardiomyopathy (ACM) is a leading cause of sudden cardiac death among young adults. Aberrant gap junction remodeling has been linked to disease-causative mutations in plakophilin-2 (). Although gap junctions are a key therapeutic target, measurement of gap junction function in preclinical disease models is technically challenging.
View Article and Find Full Text PDFPrevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study.
Mayo Clin Proc
November 2024
The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address:
Objective: To determine the prevalence, penetrance, and disease expression of cardiomyopathy-related genetic variants in an unselected, richly phenotyped Mayo Clinic population in the setting of preemptive sequencing, with return of incidental findings following the American College of Medical Genetics and Genomics recommendations.
Patients And Methods: We analyzed a quaternary medical center-based biobank cohort (n=983) for reportable variants in 15 cardiomyopathy genes. Prioritization of genetic variants was performed using an internally developed pipeline to identify potentially reportable variants.
Generation of human induced pluripotent stem cell lines UKJi001-A and UKJi006-A from patients with heterozygous mutation in the PKP2 gene.
Stem Cell Res
December 2024
Department of Internal Medicine I, Division of Cardiology, University Hospital Jena, FSU Jena, Germany.
Article Synopsis
- Researchers are exploring the genetic disorder arrhythmogenic right ventricular dysplasia 9/cardiomyopathy (ARVCD9) due to insufficient early markers and treatment options.
- They generated human induced pluripotent stem cell (hiPSC) lines from a father and son duo, both carrying the same mutation in the PKP2 gene, to study disease mechanisms.
- The hiPSC lines were created using a non-integrating Sendai virus method to reprogram the father's and son's peripheral blood cells.
Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics.
Nat Cardiovasc Res
December 2023
Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Article Synopsis
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a serious genetic heart condition linked to dangerous heart rhythms, primarily caused by mutations in the PKP2 gene, with no current effective treatments available.
- Researchers developed a mouse model with a specific PKP2 mutation that mimics ARVC symptoms, leading to sudden death at a young age.
- Treatment with AAV-PKP2 gene therapy in these mice significantly restored normal PKP2 levels, preventing heart damage and improving survival rates, suggesting a potential new therapy for ARVC related to PKP2 mutations, especially those affecting RNA splicing.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!